financetom
Business
financetom
/
Business
/
Update: NextGen Digital Platforms Up 12% as It Looks to Invest in a Blockhain-Backed Payment Solutions Provider
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: NextGen Digital Platforms Up 12% as It Looks to Invest in a Blockhain-Backed Payment Solutions Provider
Aug 29, 2025 9:37 AM

12:11 PM EDT, 08/29/2025 (MT Newswires) -- (Updates shares.)

NextGen Digital Platforms ( NXTDF ) on Friday said it signed a letter of intent for a strategic investment in Centi, an emerging leader in blockchain-powered digital payment solutions.

NextGen will invest $300,000 in Centi at a $7 million pre-money valuation, resulting in ownership of about 4.29% of Centi's issued and outstanding shares.

The investment provides NextGen with a 60-month exclusive license to deploy Centi's enterprise-grade platform in North America, NextGen said.

NextGen also secured a 24-month option to increase its interest in Centi by up to 50%.

"This investment advances our mission to bridge digital assets with traditional finance and real-world operations," said chief executive Matthew Priebe. "Centi has built a proven ecosystem of merchants and consumers already transacting daily with digital infrastructure.

"Bringing this model to North America gives NextGen an immediate foothold in the stablecoin payments space, while also positioning us at the forefront of blockchain-driven loyalty, rewards, and digital commerce innovation," Priebe added.

The companies expect to sign a definitive agreement on or before Oct. 15.

NextGen's shares were last seen up $0.06 to $0.56 on the Canadian Securities Exchange.

Price: 0.56, Change: +0.06, Percent Change: +12.00

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen, Ionis to discontinue development of ALS drug
Biogen, Ionis to discontinue development of ALS drug
May 16, 2024
May 16 (Reuters) - Biogen and Ionis Pharmaceuticals ( IONS ) said on Thursday they will terminate the development of their experimental treatment for amyotrophic lateral sclerosis (ALS) after failing to show improvement in patients in an early-to-mid stage study. ALS, commonly known as Lou Gehrig's disease, is a rare and fatal neurodegenerative disease that affects voluntary control of the...
Canada Goose Up 13% As Posts Q4 Net Income Miss, But Revs Beat; Says FY25 Outlook
Canada Goose Up 13% As Posts Q4 Net Income Miss, But Revs Beat; Says FY25 Outlook "Supersedes" All Others, But Withdraws Long Term Targets
May 16, 2024
07:51 AM EDT, 05/16/2024 (MT Newswires) -- Canada Goose (GOOS.TO) was at last look up 13% in US premarket after it reported a fourth quarter net profit miss, but big revenues beat, and also provided a Fiscal 2005 outlook that supersedes all prior financial outlook statements made by the company. Meanwhile, it withdrew long-term financial targets. The luxury outwear company...
Gazprom CEO Miller not on Putin's trip to China, Gazprom says
Gazprom CEO Miller not on Putin's trip to China, Gazprom says
May 16, 2024
MOSCOW, May 16 (Reuters) - Gazprom CEO Alexei Miller was not on Russian President Vladimir Putin's state visit to China because he was holding talks with the Iranian leadership, the gas behemoth said. Alexei Miller held talks with the Iranian leadership on the dates of Putin's visit to China, Gazprom said. Gazprom said on Wednesday that he was on a...
NICE's Eilam to step down as CEO at end of 2024 after 10 years
NICE's Eilam to step down as CEO at end of 2024 after 10 years
May 16, 2024
JERUSALEM, May 16 (Reuters) - The chief executive of NICE Barak Eilam plans to step down at the end of 2024 after a decade at the helm of the Israeli cloud-based software provider, the company said on Thursday. NICE said Eilam - who has been with the firm for 25 years in all - will remain CEO until the end...
Copyright 2023-2026 - www.financetom.com All Rights Reserved